Cardiometabolic and renal benefits of sodium–glucose cotransporter 2 inhibitors
Yong‐ho Lee, Soo Lim, Melanie J. Davies
Topics & Concepts
MedicineDiabetes mellitusTubuloglomerular feedbackPharmacologyKidneyEmpagliflozinInternal medicineInflammationEndocrinologyAnimal studiesGlycosuriaOxidative stressBioinformaticsKidney diseaseType 2 diabetesIntensive care medicineBlood pressureDipeptidyl peptidase-4Renin–angiotensin systemHemodynamicsHeart failureCotransporterCanagliflozinDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerPancreatic function and diabetes